GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medios ILM1.DE · EUR

Health Care · XETRA · 🇩🇪 Germany

Compare

10.46

-1.13%

Close of 20 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Medios — daily XETR:ILM1 End of day
Market value
€259.1m
Last close × shares
Volume
76.8k
Shares, 20 Nov 2026
Price to earnings
18.7

About Medios

Its shares trade on XETRA under the ticker ILM1.DE. It has been listed since 1 January 1999. In the fiscal year to 31 December 2025, it reported revenue of €2.08bn and net income of €15.4m. At that date it held total assets of €903.0m and shareholders' equity of €514.2m.

Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. The company is headquartered in Berlin, Berlin. The company wholesales, markets, distributes and produces various kinds of goods for pharmacies and other pharmaceutical companies. The firm also provides related services and is engaged in the acquisition and management of other companies from the pharmaceutical industry.

Figures and description from our data supplier, not checked against the company's own report.

More about Medios →

Latest on Medios

Our reporting

Next results

31 Mar 2027

Due on 31 Mar 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Medios's ticker?

Medios trades as ILM1.DE on XETRA, under ISIN DE000A1MMCC8.

What was Medios's last closing price?

10.46 on 20 Nov 2026. The figure is in EUR and is never converted.

When does Medios next report results?

Results are expected on 10 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.